ResMed

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.

CEO

Michael J. Farrell

CEOMichael J. Farrell

Employees

10,600

Employees10,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1989

Founded1989

Employees

10,600

Employees10,600

RMD Key Statistics

Market cap

37.59B

Market cap37.59B

Price-Earnings ratio

26.38

Price-Earnings ratio26.38

Dividend yield

0.88%

Dividend yield0.88%

Average volume

1.04M

Average volume1.04M

High today

$272.72

High today$272.72

Low today

$254.55

Low today$254.55

Open price

$256.21

Open price$256.21

Volume

1.68M

Volume1.68M

52 Week high

$293.81

52 Week high$293.81

52 Week low

$199.92

52 Week low$199.92

Stock Snapshot

With a market cap of 37.59B, ResMed(RMD) trades at $266.20. The stock has a price-to-earnings ratio of 26.38 and currently yields dividends of 87.7%.

On 2026-01-29, ResMed(RMD) stock moved within a range of $254.55 to $272.72. With shares now at $266.20, the stock is trading +4.6% above its intraday low and -2.4% below the session's peak.

Trading volume for ResMed(RMD) stock has reached 1.68M, versus its average volume of 1.04M.

The stock's 52-week range extends from a low of $199.92 to a high of $293.81.

RMD News

The Motley Fool 2h

ResMed Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. Thursday, January 29, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Mick Farrell Chief Financial Officer — Br...

TipRanks 4h

ResMed Announces Dividend and Strong Quarterly Earnings Growth

Resmed ( (RMD) ) has provided an update. On January 29, 2026, Resmed’s board declared a quarterly cash dividend of US$0.60 per share, payable March 19, 2026, t...

Simply Wall St 1d

ResMed Founder’s Horatio Alger Honor Highlights Brand Strength And Valuation Gap

ResMed (NYSE:RMD) founder Dr. Peter Farrell is set to receive the Horatio Alger Award for his contributions to healthcare innovation. The award includes induct...

Analyst ratings

72%

of 29 ratings

Buy

72.4%

Hold

24.1%

Sell

3.4%

More RMD News

Simply Wall St 4d

A Look At ResMed Valuation As Investors Await December 2025 Earnings Report

Advertisement Upcoming earnings as the key near term catalyst ResMed (RMD) heads into its upcoming December 2025 quarter earnings report on January 29 with ma...

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.